Cargando…

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

STUDY QUESTION: Is it possible to reduce the cost of GnRH agonist treatment for endometriosis by using non-standard dosing regimens? SUMMARY ANSWER: An extended-interval dosing regimen of a 3.75 mg depot formulation of triptorelin injected every 6 weeks instead of every 4 weeks reduces the cost by o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vercellini, Paolo, Bandini, Veronica, Buggio, Laura, Barbara, Giussy, Berlanda, Nicola, Dridi, Dhouha, Frattaruolo, Maria Pina, Somigliana, Edgardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067151/ https://www.ncbi.nlm.nih.gov/pubmed/37016694 http://dx.doi.org/10.1093/hropen/hoad008

Ejemplares similares

The Subjective Experience of Dyspareunia in Women with Endometriosis: A Systematic Review with Narrative Synthesis of Qualitative Research
por: Facchin, Federica, et al.
Publicado: (2021)

Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021)

Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care
por: Buggio, Laura, et al.
Publicado: (2017)

GnRH agonists in the treatment of symptomatic endometriosis: a review
por: Surrey, Eric S.
Publicado: (2022)

Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review
por: Kuan, Kevin K.W., et al.
Publicado: (2023)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence
por: Barbara, Giussy, et al.
Publicado: (2021)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

Use of GnRH Agonist in Dogs Affected with Leishmaniosis
por: Pugliese, Michela, et al.
Publicado: (2021)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
por: Kaur, Harpreet, et al.
Publicado: (2012)

Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders
por: Fàbregues, Francesc, et al.
Publicado: (2019)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

"You can't always get what you want": from doctrine to practicability of study designs for clinical investigation in endometriosis
por: Vercellini, Paolo, et al.
Publicado: (2015)

Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017)

Melatonin Inhibits GnRH-1, GnRH-3 and GnRH Receptor Expression in the Brain of the European Sea Bass, Dicentrarchus labrax
por: Servili, Arianna, et al.
Publicado: (2013)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

GnRH agonist-triggering ovulation in women with advanced age
por: Rahav Koren, Roni, et al.
Publicado: (2022)

Clinical development of the GnRH agonist leuprolide acetate depot
por: Chwalisz, Kristof
Publicado: (2022)

Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects
por: Whitaker, L.H.R., et al.
Publicado: (2022)

Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery
por: Tang, Mingjun, et al.
Publicado: (2023)

Clinical Features and Management of Umbilical Endometriosis: A 30 Years’ Monocentric Retrospective Study
por: Dridi, Dhouha, et al.
Publicado: (2022)

Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
por: Kaur, Harpreet, et al.
Publicado: (2012)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(−/−) mice
por: Knutsson, Anki, et al.
Publicado: (2016)

GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles
por: de Oliveira Filho, Condesmar M., et al.
Publicado: (2021)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
por: Zhao, Depeng, et al.
Publicado: (2023)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
por: Tan, Jifan, et al.
Publicado: (2023)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019)

Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey
por: Vercellini, Paolo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_489o8aah6nve2h73ki3b5d6uh3